Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Change in Inventory (2016 - 2025)

Amicus Therapeutics filings provide 10 years of Change in Inventory readings, the most recent being $44.3 million for Q4 2025.

  • On a quarterly basis, Change in Inventory rose 268.52% to $44.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $111.5 million, a 51.36% increase, with the full-year FY2025 number at $111.5 million, up 51.36% from a year prior.
  • Change in Inventory hit $44.3 million in Q4 2025 for Amicus Therapeutics, up from $36.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $44.3 million in Q4 2025 to a low of -$1.8 million in Q1 2022.
  • Median Change in Inventory over the past 5 years was $6.7 million (2021), compared with a mean of $12.1 million.
  • Biggest five-year swings in Change in Inventory: crashed 395.22% in 2021 and later soared 1510.14% in 2023.
  • Amicus Therapeutics' Change in Inventory stood at $4.8 million in 2021, then soared by 115.1% to $10.3 million in 2022, then tumbled by 76.78% to $2.4 million in 2023, then skyrocketed by 404.83% to $12.0 million in 2024, then soared by 268.52% to $44.3 million in 2025.
  • The last three reported values for Change in Inventory were $44.3 million (Q4 2025), $36.3 million (Q3 2025), and $22.6 million (Q2 2025) per Business Quant data.